Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2005
01/06/2005WO2005001417A2 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof
01/06/2005WO2005001416A2 High throughput assay of lp-pla2 activity
01/06/2005WO2005001131A2 Methods for diagnosing mood disorders
01/06/2005WO2005001118A2 Detection system
01/06/2005WO2005001112A2 RIBOSOMAL RNA METHYLTRANSFERASES R1mA: TARGET VALIDATION AND PROCESSES FOR DEVELOPING AN INHIBITOR ASSAY AND IDENTIFICATION CANDIDATE INHIBITORS
01/06/2005WO2005001100A2 Plant fatty acid amide hydrolases
01/06/2005WO2005001089A1 Method of detecting cancer
01/06/2005WO2005001085A1 Mouse exhibiting characteristics of rosmond thomson syndrome and method of preparation thereof
01/06/2005WO2005001084A2 Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses
01/06/2005WO2005001083A1 Regulation of kinase, ´regulated in copd kinase´ (rc kinase)
01/06/2005WO2005001065A2 Variant humicola grisea cbh1.1
01/06/2005WO2005001064A2 Polypeptides having alpha-amylase activity and polypeptides encoding same
01/06/2005WO2005001062A2 Modified vectors for organelle transfection
01/06/2005WO2005001057A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
01/06/2005WO2005001052A2 Modulation of apoptosis
01/06/2005WO2005001051A2 Compositions and methods for regulating polysaccharides of a plant cell
01/06/2005WO2005001041A2 Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
01/06/2005WO2005001036A2 Novel trichoderma genes
01/06/2005WO2005001034A2 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
01/06/2005WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids
01/06/2005WO2005001024A2 Genes encoding carotenoid compounds
01/06/2005WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
01/06/2005WO2005000882A2 Dna fragments and proteins encoded by said dna isolated from bifidobacteria
01/06/2005WO2005000352A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine
01/06/2005WO2005000342A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy
01/06/2005WO2005000200A2 Novel kinases
01/06/2005WO2004090155A3 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger
01/06/2005WO2004056989A3 Human variants of kallikrein-2 and kallikrein-3 and uses thereof
01/06/2005WO2003070925A9 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity
01/06/2005WO2003020890A3 Genes encoding baeyer-villiger monooxygenases
01/06/2005US20050005333 Isolated polynucleotide encoding a transcription factor; suppressing endogenous expression of chalcone synthase, leucoanthocyanidin dioxygenase and phenylalanine ammonia lyase
01/06/2005US20050005331 Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants
01/06/2005US20050005330 Transformation using nucleotide sequence for antisense inhibition or sense suppression of endogenous lysine ketoglutarate reductase/saccharopine dehydrogenase activity
01/06/2005US20050005329 Isolated nucleotide sequence encoding polypeptide derived from algae Isochrysis galbana; expression of vector results in production of polyunsaturated fatty acid; use in pharmaceutical compositions, animal feeds and cosmetics
01/06/2005US20050005328 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics
01/06/2005US20050005327 Transforming corn kernel tissue with an expressio cassette comprising isolated nucleic acid molecule encoding polypeptide; expression of GBSS (granule bound starch synthase) allele
01/06/2005US20050005326 Use of class enzymes and their encoding genes to increase the oil content in transgenic organisms
01/06/2005US20050005325 Mutant fatty acid desaturase and methods for directed mutagenesis
01/06/2005US20050005324 Gene promoters isolated from potato and use thereof
01/06/2005US20050005323 Using expression vector comprising nucleotide sequences coding sucrose isomerase as tool in generating transgenic plants with increased carbohydrate concentration; for use in fermenting compounds such as methanol, ethanol and 1,3 propandiol
01/06/2005US20050005322 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
01/06/2005US20050005315 Animals with high histamine productivity
01/06/2005US20050005314 Animal model comprising constitutively exprressed anaplastic lymphoma kinase (ALK) gene for use in identifying agents which prevent and treat tumor metastasis; gene expression inhibition; RNA interference; immunotherapy
01/06/2005US20050005312 Propagation of human hepatocytes in non-human animals
01/06/2005US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis
01/06/2005US20050004030 Degradation spores; infection therapy
01/06/2005US20050004024 Methods of treating Pin1 associated disorders by covalent modification of active site residues
01/06/2005US20050003986 Mutants in subtilisin gene; detergents; oxidation resistance
01/06/2005US20050003985 From Bacillus; hybrid protein; detergents, cleaning compounds
01/06/2005US20050003549 Nucleotide sequences coding methyltransferase for use in identifying modulators for treatment of respiratory disorders in cattle; veterinary medicine
01/06/2005US20050003542 Enhanced sleeping beauty transposon system and methods for using the same
01/06/2005US20050003541 Transgenic embryonic stem cells comprising vector coding RNA interfering sequences for use in generating gene knockout animal models; gene expression analysis
01/06/2005US20050003540 Altered recombinases for genome modification
01/06/2005US20050003516 Treating paper making pulp with pectin lyase, pectate lyase and/or combinations of pectate lyase and pectinesterase for use in preparing pulps for paper materials such as cardboard, linerboard, corrugated paperboard, tissue, towels, corrugated containers or boxes
01/06/2005US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease
01/06/2005US20050003503 Microbulbifer culture for use in the generation of agarase and chitinase for use in mixture for treatment and prevention of bacterial infection
01/06/2005US20050003502 Protein linked polynucleotide for use as therapeutic preventative in treatment of cancer, viral disease and microbial infection
01/06/2005US20050003500 Producing optically active vicinal diols via reacting (2S,3S)-2,3-butanediol dehydrogenase, microorganism, 2,3-butanedione and (2S,3S)-2,3-butanediol in presence of reduced nicotinamide adenine dinucleotides; for use as raw material in flavors and pharmeceuticals
01/06/2005US20050003487 Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same
01/06/2005US20050003486 Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester alpha-N-acetyl glucosimanidase
01/06/2005US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy
01/06/2005US20050003478 Transforming pasturella with expression vector comprising nucleotide sequences coding acetylglucosaminyltransferase; bioreactors
01/06/2005US20050003476 Nove glycosyltransferase genes
01/06/2005US20050003474 Carotenoid biosynthesis
01/06/2005US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
01/06/2005US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders
01/06/2005US20050003442 Delta4-desaturase genes and uses thereof
01/06/2005US20050003434 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
01/06/2005US20050003432 Detection of nuceic acids by multiple sequential invasive cleavages
01/06/2005US20050003425 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders
01/06/2005US20050003420 Recycled mutagenesis of restriction endonuclease toward enhanced catalytic activity
01/06/2005US20050003419 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles
01/06/2005US20050003416 Novel modified corin molecules having substitute activation sequences and uses thereof
01/06/2005US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease
01/06/2005US20050003409 Expression vector comprising nucleotide sequences coding polyketide synthase for use in transformation, and propagation of streptomyces cells capable of producing moxidectin; bactericides; nematocide
01/06/2005US20050003401 Expression vector comprising nucleotide sequences coding archaeal replication factor A (RFA) for use in generating polypeptide which enhances stability and efficacy of gene amplification products
01/06/2005US20050003389 Computationally targeted evolutionary design
01/06/2005US20050003388 Expression vector comprising nucleotide sequences coding hydrolase for use in identifying modulators which treatment and/or prevent nervous system and inflammatory disorders
01/06/2005US20050003383 Linoleate isomerase
01/06/2005US20050003382 Streptomyces culture for use in the digestion of degradation resistant protein in waste water, organic waste liquids and industrial wastes; bioremediation
01/06/2005US20050003368 Cancer monitoring and therapeutics
01/06/2005US20050003365 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo
01/06/2005US20050003354 Generating enhanced regulatory region via random rearrangement of transcriptional activating components; immproving efficiency ofheterologous gene expression
01/06/2005US20050003348 Drug screening/design; crystal structure; replication-defective
01/06/2005US20050002950 Vaccine preventing infection
01/06/2005US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers
01/06/2005US20050002923 Thermostable uvra, uvrb, and uvrc polypeptides and methods of use
01/06/2005US20050002917 Regulation of Acheron expression
01/06/2005US20050002897 Biological entities and the pharmaceutical or diagnostic use thereof
01/06/2005US20050000807 Biosensor with multi-channel A/D conversion and a method thereof
01/06/2005US20050000666 Controlled pH and temperature; heating; papermaking ; high strength
01/06/2005CA2771875A1 Variant humicola grisea cbh1.1
01/06/2005CA2538349A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same
01/06/2005CA2530248A1 Modified vectors for organelle transfection
01/06/2005CA2530020A1 Novel .beta.-actin and rps21 promoters and uses thereof
01/06/2005CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy
01/06/2005CA2529341A1 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
01/06/2005CA2528544A1 Compositions and methods for regulating polysaccharides of a plant cell
01/06/2005CA2527959A1 Plant fatty acid amide hydrolases
01/06/2005CA2527648A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine